Deutsche Bank’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Buy
200,248
+47,602
+31% +$206K ﹤0.01% 2276
2026
Q1
$591K Buy
152,646
+16,837
+12% +$69.1K ﹤0.01% 2488
2025
Q4
$568K Buy
135,809
+47,409
+54% +$183K ﹤0.01% 2500
2025
Q3
$291K Buy
88,400
+14,911
+20% +$42.1K ﹤0.01% 2869
2025
Q2
$104K Sell
73,489
-17,542
-19% -$24.9K ﹤0.01% 3237
2025
Q1
$136K Buy
91,031
+23,729
+35% +$37.4K ﹤0.01% 3115
2024
Q4
$75.4K Hold
67,302
﹤0.01% 3356
2024
Q3
$63.9K Buy
67,302
+26,136
+63% +$33K ﹤0.01% 3311
2024
Q2
$65K Sell
41,166
-13,388
-25% -$19.4K ﹤0.01% 3268
2024
Q1
$79.1K Sell
54,554
-2,694
-5% -$3.87K ﹤0.01% 3260
2023
Q4
$76.7K Hold
57,248
﹤0.01% 3332
2023
Q3
$81.3K Hold
57,248
﹤0.01% 3250
2023
Q2
$65.8K Sell
57,248
-20,586
-26% -$24.3K ﹤0.01% 3416
2023
Q1
$82.5K Buy
77,834
+36,549
+89% +$52.7K ﹤0.01% 3406
2022
Q4
$62.8K Buy
41,285
+675
+2% +$1.16K ﹤0.01% 3507
2022
Q3
$86K Sell
40,610
-6,743
-14% -$14.2K ﹤0.01% 3401
2022
Q2
$63K Sell
47,353
-6,519
-12% -$9.67K ﹤0.01% 3695
2022
Q1
$114K Sell
53,872
-6,616
-11% -$16.1K ﹤0.01% 3537
2021
Q4
$225K Buy
60,488
+3,053
+5% +$13.1K ﹤0.01% 3323
2021
Q3
$286K Sell
57,435
-1,758
-3% -$10.1K ﹤0.01% 3365
2021
Q2
$386K Buy
59,193
+13,980
+31% +$97.7K ﹤0.01% 3387
2021
Q1
$311K Sell
45,213
-4,122
-8% -$34.8K ﹤0.01% 3392
2020
Q4
$503K Sell
49,335
-1,648
-3% -$10.7K ﹤0.01% 2896
2020
Q3
$178K Buy
50,983
+10,463
+26% +$49.7K ﹤0.01% 3283
2020
Q2
$202K Buy
40,520
+17,133
+73% +$58.3K ﹤0.01% 3140
2020
Q1
$80K Sell
23,387
-7,874
-25% -$34K ﹤0.01% 3342
2019
Q4
$170K Buy
31,261
+12,557
+67% +$70.7K ﹤0.01% 3318
2019
Q3
$106K Sell
18,704
-2,498
-12% -$17K ﹤0.01% 3513
2019
Q2
$160K Sell
21,202
-64,685
-75% -$348K ﹤0.01% 3953
2019
Q1
$449K Sell
85,887
-180,417
-68% -$1.25M ﹤0.01% 3519
2018
Q4
$1.74M Sell
266,304
-635,900
-70% -$7.13M ﹤0.01% 2496
2018
Q3
$15.5M Buy
902,204
+177,758
+25% +$2.64M 0.01% 1300
2018
Q2
$10.1M Buy
724,446
+545,630
+305% +$9.22M 0.01% 1743
2018
Q1
$2.74M Buy
178,816
+172,022
+2,532% +$2.46M ﹤0.01% 2662
2017
Q4
$76K Sell
6,794
-9,113
-57% -$136K ﹤0.01% 4331
2017
Q3
$301K Buy
15,907
+2,328
+17% +$47.9K ﹤0.01% 3666
2017
Q2
$324K Sell
13,579
-87,277
-87% -$1.91M ﹤0.01% 3682
2017
Q1
$2M Sell
100,856
-39,730
-28% -$887K ﹤0.01% 2243
2016
Q4
$3.38M Sell
140,586
-135,765
-49% -$3.78M ﹤0.01% 1917
2016
Q3
$7.67M Sell
276,351
-82,807
-23% -$2.19M 0.01% 1477
2016
Q2
$8.76M Buy
359,158
+338,629
+1,650% +$9.61M 0.01% 1384
2016
Q1
$687K Sell
20,529
-145,864
-88% -$4.59M ﹤0.01% 3026
2015
Q4
$4.97M Buy
166,393
+101,064
+155% +$3.41M ﹤0.01% 1793
2015
Q3
$2.06M Sell
65,329
-93,898
-59% -$4.58M ﹤0.01% 2470
2015
Q2
$7.7M Buy
159,227
+92,066
+137% +$3.88M ﹤0.01% 1509
2015
Q1
$2.91M Sell
67,161
-86,771
-56% -$3.12M ﹤0.01% 2178
2014
Q4
$4.05M Sell
153,932
-17,964
-10% -$394K ﹤0.01% 2126
2014
Q3
$3.05M Buy
171,896
+160,178
+1,367% +$3.27M ﹤0.01% 2205
2014
Q2
$280K Sell
11,718
-4,515
-28% -$91.5K ﹤0.01% 3904
2014
Q1
$407K Buy
16,233
+4,575
+39% +$127K ﹤0.01% 3467
2013
Q4
$264K Sell
11,658
-12,127
-51% -$245K ﹤0.01% 3520
2013
Q3
$538K Buy
+23,785
New +$549K ﹤0.01% 3435

Other funds holding PGEN

Deutsche Bank's PGEN Position: Q2 2026 in Review

Deutsche Bank increased its Precigen (PGEN) stake by 31% in Q2 2026, buying an estimated $206K and bringing the position to 200,248 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

Deutsche Bank first reported a position in PGEN in Q3 2013 and has held it in 52 quarters since. The position peaked at $15.5M in Q3 2018. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Deutsche Bank held 200,248 shares of Precigen worth $1.14M as of Q2 2026.
  • Deutsche Bank bought 47,602 Precigen shares in Q2 2026, an estimated $206K.
  • Precigen made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2276 holding.
  • Deutsche Bank first reported a position in Precigen in Q3 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Precigen position peaked at $15.5M in Q3 2018.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.